COVID-19 Study Reveals Increased Risk of Neurological Disorder in SARS-CoV-2 Patients

Strategic Insights -

Researchers from Chung Shan Medical University have published a new study on the association between COVID-19 and a rare neurological disorder, acute transverse myelitis (ATM). The study examined the incidence of ATM in SARS-CoV-2 patients and identified a significantly higher risk of developing ATM compared to non-infected individuals. The research also found no statistical significance between patients with and without SARS-CoV-2 infection after receiving different SARS-CoV-2 vaccines.

Key Takeaways:

  • The study found a significantly higher risk of developing ATM in SARS-CoV-2 patients compared to non-infected individuals, with a hazard ratio (HR) of 1.46 and a 95% confidence interval (CI) of 1.21-1.74.
  • Stratified analyses confirmed the increased risk across various subgroups, including patients younger and older than 65 years, both males and females, and those infected during the Alpha strain-dominant period.
  • No statistical significance was found between patients with and without SARS-CoV-2 infection after receiving different SARS-CoV-2 vaccines.
  • The study concluded that SARS-CoV-2 infection appears to be more strongly associated with ATM than COVID-19 vaccination.
  • Further studies are warranted to explore the underlying mechanisms and preventive strategies for ATM in SARS-CoV-2 patients.

The study's findings have significant implications for public health and vaccination strategies. The researchers emphasized the need for further investigation into the underlying mechanisms and preventive strategies for ATM in SARS-CoV-2 patients.

Statistics:

  • 1.46: Hazard ratio (HR) of developing ATM in SARS-CoV-2 patients compared to non-infected individuals
  • 1.21-1.74: 95% confidence interval (CI)
  • 65 years: Age group used in stratified analyses
  • 2020-2023: Time period examined in the study
  • 1 year: Follow-up period used in the study

Sources:

  • Acute transverse myelitis and associate vaccine complication in SARS-CoV-2 patients: a retrospective cohort analysis in real-world database. Virology Journal, 2025;22(1):277.
  • Virology Journal can be contacted at: Bmc, Campus, 4 Crinan St, London N1 9XW, England. (BioMed Central - www.biomedcentral.com/; Virology Journal - www.virologyj.com)